Meet our dedicated executives who lead our company,
guiding our clinical research and development efforts with
unparalleled expertise and a commitment to advancing
healthcare solutions.
Dr. Lackner is a highly experienced global thought leader with over 20 years in the healthcare industry.
She previously held the CSO position at Element Materials, where she drove technical excellence and scientific rigor, contributing to the company’s growth and global expansion. Before this, she was Managing Director at Vineta, a family office specializing in long-term investments in Life Sciences. She also led the merger of ABF Pharmaceutical Services and GBA Group Pharma, transforming the company into a trusted international partner for the pharma and biotech industries.
Dr. Lackner is a Qualified Person (QP) and a respected advisor in the life sciences field. She holds a PhD in Pharmacy from the University of Vienna, a Master’s degree in Tumor Biology, and serves on the boards of several companies.
Professor Forst is a board-certified physician in internal medicine, endocrinology, and diabetes, currently serving as Chief Medical Officer and Chairman of the Executive Board at CRS.
Professor Forst teaches Internal Medicine and Endocrinology at Johannes Gutenberg University in Mainz, Germany. Over the past 30 years, he has participated in over 300 clinical trials, focusing on obesity, metabolic syndrome, fatty liver disease, diabetes, and cardiovascular complications. He chairs the Diabetes and Heart study group and is a board member of the Neuropathy study group of the German Diabetes Association.
He has authored or co-authored over 300 articles in peer-reviewed journals and serves on the editorial boards of several national and international specialty publications.
Catherine brings over 20 years of experience in clinical research services to CRS, excelling in business development, growth strategy, and strategic marketing.
She previously served as European Sales Director, Business Development Coach, and Senior Director of Strategic Accounts at Labcorp Central Laboratory Services, where she led efforts in business development, marketing, and sales for the biotech sector. Catherine was also Senior Director of Business Development at Labcorp Drug Development (now Fortrea), overseeing global commercial relationships. Earlier, she was Director of Business Development at Premier Research, driving growth in Phase I-IV clinical development services.
Catherine holds a Master’s in Business Sciences from Lugano Business School and has completed post-graduate training in marketing, executive coaching, clinical trials, and regulatory affairs.
